US 8444996
Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia
granted A61KA61K39/015A61K47/646
Quick answer
US patent 8444996 (Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K39/015, A61K47/646, A61P, A61P33/06